Skip to main content
TipRanks
Go Ultimate75% OFF

Robert Peabody Insider Profile

4 Followers

Robert Peabody, Sr. VP and CFO at Lineage Therap, holds 41.00 shares in Asterias Biotherapeutics (Ticker: AST), holds 631.55K shares in Lineage Therap (Ticker: LCTX), holds 0.00 shares in Ocata Therapeutics (Ticker: OCAT).

Robert Peabody's Trading History

AST
Asterias Biotherapeutics
Aug 19, 2014―Uninformative Buy―$38.74
LCTX
Lineage Therap
Jul 23, 2014Sr. VP and CFOInformative Sell502.50K$502.09K
OCAT
Ocata Therapeutics
―――$0.00

You May Also Like

Robert Peabody insider profile FAQ

What is the percentage of profitable transactions made by Robert Peabody?
The percentage of profitable transactions made by Robert Peabody is 33%.
What is the average return per transaction made by Robert Peabody?
The average return per transaction made by Robert Peabody is -3.00%.
What stocks does Robert Peabody hold?
Robert Peabody holds: LCTX, AST, OCAT stocks.
What was Robert Peabody's most profitable transaction?
Robert Peabody’s most profitable transaction was an Informative Buy of LCTX stock on July 23, 2014. The return on the trade was 18.50%.
What is Robert Peabody's role in Lineage Therap?
Robert Peabody's role in Lineage Therap is Sr. VP and CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.